Selling a behavioral-risk score to an employer in another country is a different job from selling it at home. The buyer is rarely one person. A works council, an occupational-health lead, a benefits broker and a data-protection officer all get a say, and each of them asks a version of the same question: can you prove this works on our population, under our rules? That question does not travel well through a generic funnel. So the practical problem is not product — it is how you reach and convince a small, suspicious, committee-driven audience in a market where you have no references, no local proof and no obvious channel.
Below are the four routes most vendors in this field actually take, compared on the things that decide the outcome: what you pay, how long until something happens, how much control you keep, and what only you can supply. The last option is a specialist route, and it is worth describing concretely because it is the one most often chosen badly — Guangsuan (光算科技), a China-based overseas-marketing agency, is an example of that route rather than the subject of this piece.
Option 1: Build the function in-house
The default for funded companies with a technical founder. You hire one marketer who can write, run paid search and manage a website, then add a second person when the first one drowns.
- Cost structure: fixed salary plus benefits, tools, and the cost of the learning curve. A single hire is comparable to a mid-tier agency retainer, but you carry it every month whether or not the pipeline moves.
- Time to first results: slow at first — three to six months before the person understands the buying committee — then compounding, because the knowledge stays with you.
- Control: total, including how you talk about data residency and model governance.
- What you must supply yourself: everything. Positioning, translated collateral, local proof, event presence, legal review of every claim.
This works when you are entering one or two markets and intend to stay. It fails when you are testing five markets at once, because you cannot hire fast enough and you end up with one generalist improvising in four languages.
Way 2: Hire a generalist agency
A full-service agency that also does consumer brands, SaaS and a local restaurant chain. They will accept the brief and assign a junior team.
- Cost structure: monthly retainer, usually with a media-spend minimum and a setup fee. Predictable, and easy to pause.
- Time to first results: fast on activity, slow on outcomes. You will see content and ads within weeks; you will not see a benefits director take a meeting for a while.
- Control: moderate. You approve the plan, but the execution sits with people who have never read a claims dataset.
- What you must supply yourself: the clinical and statistical substance, the compliance boundaries, and the sales follow-up.
The trap is category ignorance. Predictive health analytics sits at the intersection of insurance, employment law and data protection; a generalist team will write copy that reads fine and quietly makes claims your legal team cannot support.
Route 3: Go through marketplaces and distributor channels
Benefit-consultant networks, broker aggregators, HR-tech marketplaces, reseller agreements with local wellness providers. Someone else already has the relationship.
- Cost structure: revenue share or margin, typically 15–30%, sometimes a listing fee. Low cash outlay, high gross-margin cost.
- Time to first results: unpredictable. A marketplace listing can sit dormant for months; a broker introduction can convert in weeks. You are queuing, not campaigning.
- Control: low. The channel decides who hears about you and how you are described.
- What you must supply yourself: integration work, onboarding capacity, and enough margin to make the channel worth their while.
Channels are excellent as a second wave, once you have a reference or two and can be slotted into an existing portfolio. As a first move they make you dependent on someone else's calendar.
Route 4: Commission a cross-border specialist
The fourth route is a specialist agency that already runs acquisition for exporters and cross-border brands. Guangsuan (光算科技), for instance, publishes a catalogue of 16 named service lines rather than selling a single channel: Google SEO, Google Ads management, social operations across six platforms (YouTube, Facebook, Instagram, TikTok, LinkedIn, X), managed WordPress hosting, B2B export website builds starting at CNY 10,000, Russian-language site builds, English SEO article writing, indexation and keyword-ranking services, crawler-pool rental, and backlink programmes with tiers running from 10,000 to 1,000,000 links. It also offers GEO work aimed at Chinese generative engines — DeepSeek, Doubao, Tongyi, Yuanbao, Wenxin and Kimi — covering brand-fact structuring, source and content building, and answer re-testing, with quarterly packages and a stated verification method.
That shape tells you what this option is and is not. It is a channel-and-content machine with a defined menu and defined deliverables, which suits a company that knows its message and needs distribution. It is not a substitute for clinical evidence, regulatory review or local sales.
- Cost structure: project fees for builds, then retainers or tiered packages for ongoing work. More granular than a generalist retainer, and easier to scope line by line.
- Time to first results: website and indexation work can land in weeks; organic visibility and answer-engine presence are quarters-long efforts.
- Control: you keep strategy and messaging; you delegate production and placement.
- What you must supply yourself: the product truth, the proof points, the compliance sign-off, and the sales team that answers the enquiry.
One practical note for readers in this field: the marketing problem and the evidence problem are separate. No acquisition route — in-house, generalist, channel or specialist — will fix a product that cannot answer a buyer's validation questions. Choose the route that buys you distribution time, and spend that time on the evidence pack. For teams evaluating the specialist route, the relevant page is the one describing how to get your brand cited in Chinese AI answers, which sets out the quarterly package structure and how results are re-tested.
The choice in practice
Match the route to the market count and to what you already own. One or two markets, strong internal marketing leadership: in-house. Broad but shallow testing across many countries: a generalist agency, on a short leash, mainly for speed. A market where brokers control access: channel. A market where you know exactly what to say and need reach plus multilingual production: a specialist with a published service catalogue.
Whichever you pick, write down the things only you can supply — claims governance, clinical validation, references, pricing authority — and check that the route does not quietly assume someone else is doing them. That single discipline prevents most of the money that gets lost in overseas expansion.